<DOC>
	<DOC>NCT01607684</DOC>
	<brief_summary>The purpose of this study is to determine whether Magnetic Marker Monitoring is an appropriate opportunity to diagnose and to quantify a suspicious gastroparesis in subjects with diabetic polyneuropathy.</brief_summary>
	<brief_title>Pilot Study to Evaluate Magnetic Marker Imaging on Diabetic Polyneuropathy and Gastroparesis</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Gastroparesis</mesh_term>
	<mesh_term>Polyneuropathies</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<criteria>age &gt; 50 years written informed consent Diabetes mellitus (only Diabetes mellitus group) Symptoms of diabetic gastroparesis with respect to nausea, postprandial fullness, abdominal pain, nausea, vomiting, abdominal bloating, early satiety, erratic blood glucose levels and weight loss evaluated by a standardized questionnaire (only Diabetes mellitus group) actually measured HbA1c (only Diabetes mellitus group) Subject who is pregnant or breast feeding. Subject unwilling or unable to comply with study requirements. Any investigational agent or participation in another clinical trial within 28 days prior to randomization Any kind of disorder that compromises the ability of the subject to give written informed consent and/or comply with the study procedures. History of any medical condition that may increase the risks associated with study participation or may interfere with the interpretation of the study results. Known allergy to the investigational product, to any of its excipients Active inflammatory bowel disease, serious gastric ulceration or other bowel diseases like e.g. coeliac disease Implanted cardiac cardioverterdefibrillator or cardiac pacemaker Stenosis or stricture of gastrointestinal tract or any surgery in this region except for cholecystectomy or appendectomy Longterm medication with drug, that influence gastrointestinal motility (opiate, opioids, erythromycin, metoclopramide, laxatives) &lt; 3 days before randomisation and before magnetic marker monitoring</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
</DOC>